Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

Affiliated Hospital of Jiangnan University30 enrolled

Overview

This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Liver Carcinoma

Interventions

18F-RD2RADIATION

Patients will receive 5-10 mCi 18F-RD2

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with highly suspected tumor； 2. Patients underwent PET/CT examination within 1 week; 3. Patients voluntarily signed informed consent; 4. Over 18 years old, male or female. Exclusion Criteria: 1. Pregnant women; 2. Lactating women; 3. Patients with impaired renal function.

Locations (1)

Affiliated Hospital of Jiangnan University

Wuxi, Jiangsu, China

Outcomes

Primary Outcomes

Evaluation of tissue distribution of 18F-RD2

Biodistribution of 18F-RD2 evaluated by radioactive uptake values (standardized uptake values, SUVs) in various organs during repeated 18F-RD2 scans will be reported.

Time frame: 2 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.